Transcription factor Six1a plays important roles in morphogenesis, organogenesis, and cell differentiation.
Introduction

41
During embryogenesis, the trunk and limb muscles originate from 
139
In this study, we focus on the role of Six1a in head myogenesis.
140
When Six1a is absent by injection of six1a-specific morpholino (MO), 141 we show that myf5 fails to express in the cranial muscles that 142 originate from trunk paraxial mesoderm, whereas myf5 continues to 
Materials and methods
155
Fish embryos
156
The wild-type AB strain (University of Oregon, Eugene, OR) and the
in which we changed the nt 145-166 of zebrafish six1a cDNA (GenBank The transcript of six1a in the olp, ov, and allg at 24 hpf (A); in the mr, ir, 1st, 2nd, and 3rd arches at 32 and 36 hpf (D, G); and in all the cranial muscles at 72 hpf (J, L). The myf5 transcript was detected in the craniofacial region at 24 hpf (B, arrow); in the so, io, 2nd and 3rd arches at 32 hpf (E); and in the so, io, and 3rd arches at 36 hpf (H). Although the myod was not expressed in the craniofacial muscles at 24 hpf (C), it was detected in the mr/ir, lr, and 1st arch at 32 hpf (F); in the mr, ir, sr, lr, MP, IM, CHD, and CHV at 36 hpf (I); and in all the cranial muscles at 72 hpf (K, M). The schematic diagram illustrates the expression of six1a in the cranial muscles during 32-72 hpf (N). ah, adductor hyoideus; allg, anterior lateral line and vestibular ganglia; am, adductor mandibulae; ao, adductor operculi; do, dilator operculi; dpw1-5, dorsal pharyngeal wall 1-5; hh, hyohyoideus; ih, interhyoideus; ima, intermandibularis anterior; imp, intermandibularis posterior; io, inferior oblique; ir, inferior rectus; lap, levator arcus palatini; lr, lateral rectus; mr, medial rectus; olp, olfactory placode; ov, otic vesicle; sh, sternohyoideus; so, superior oblique; sr, superior rectus and tv 1-5, transversus ventralis 1-5. CHD: the constrictor hyoideus dorsalis, which differentiates to ah and ao; CHV: the constrictor hyoideus ventralis, which differentiates to ih and hh; IM: the intermandibularis, which differentiates to ima and imp; MP: the masticatory plate, which differentiates to CD and am. CD: the constrictor dorsalis, which differentiates to lap and do. Six1a is required for the development of mr, ir, sh and all pharyngeal muscles. Embryos derived from the transgenic line Tg(α-actin:RFP) (A-H), all of whose skeletal muscles appear as red fluorescent protein (RFP), were injected with 8 ng of six1a-morpholino oligonucleotide (MO) to specifically inhibit six1a mRNA translation. RFP signal was detected only in the so, io, sr, lr, and remnant dorsal branchial arch muscle (white star) primordia in the six1a-MO-injected embryos (A vs. C and B vs. D). When embryos were injected with 8 ng of six1-MO together with 150 pg of six1a mRNA, results showed that the defective muscle primordia induced by six1a-MO were rescued and appeared as RFP-labeled muscles (E, F; the rescued muscles are marked in green typeface). In contrast, the rescue experiment failed when embryos were injected with 8 ng of six1a-MO with 200 pg of gfp mRNA (G, H), suggesting that the defects of six1a morphants were specific. The expressions of myf5 (I, J, M, N), myod (K, O), and myogenin (L, P) were also observed at the stages indicated. When wild-type embryos were injected with six1a-MO, myf5 was expressed normally in the six1a morphants, both at 36-(I vs. M) and at 48-hpf (J vs. N), except sh. On the other hand, the expressions of myod (K vs. O) and myogenin (L vs. P) were decreased in the extraocular io, so, sr and lr in the six1 morphants at 48 hpf. Weak signals of myod and myogenin were also noticed in the remnant dorsal branchial muscles (black stars) of six1a morphants. The schematic diagram illustrates the cranial muscle defects in six1a morphants and compares the expressions of myf5, myod and myogenin between wild-type (upper row, Q) and six1a morphants (lower row, Q). Lateral view: A, C, E, G and I-P; and ventral view: B, D, F and H. ah, adductor hyoideus; am, adductor mandibulae; ao, adductor operculi; do, dilator operculi; hh, hyohyoideus; ih, interhyoideus; ima, intermandibularis anterior; imp, intermandibularis posterior; io, inferior oblique; ir, inferior rectus; lap, levator arcus palatini; lr, lateral rectus; mr, medial rectus; sh, sternohyoideus; so, superior oblique and sr, superior rectus. The morphological defects were observed at 72 hpf. Absent-muscle defect indicated that mr, ir, sh and ventral arch muscles were completely lost but remnants of dorsal arch muscles still remained. Reduced-muscle defect indicated that mr, ir, sh and all arch muscles were partially lost. Wild-type like phenotype indicated that the head muscles were not lost. t1:11 Fig. 3 . Loss of Six1a function does not impede the normal development of mesoderm core and pharyngeal pouch. The expression patterns of et1, fgf3 and dlx2 were examined in the wild-type and in the six1a-MO-injected embryos at 36 hpf. Results showed that the transcripts of et1, fgf3 and dlx2 exhibited similarly in ventral mesoderm cores (A vs. B, arrows), pharyngeal pouches (C vs. D, arrows), and neural crest cells (E vs. F, six arches), respectively, between wild-type embryos and six1a morphants.
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and Supplemental Fig. S4 ). However, we also observed that the sh, fb 409 and phm were absent in the six1a-MO-injected embryos derived from 410 the transgenic line Tg (α-actin:RFP) at 72 hpf (Fig. 5D ). In addition, (Figs. 5K, L) . Similarly, the expressions of myf5 and myogenin were 422 also partially rescued in the embryos co-injected with myod mRNA 423 and six1a-MO (Figs. 5N, O) . Thus, we concluded that six1a is required N) , and 8 ng of six1a-MO and 50 pg of myod mRNA (O, P) were used to examine the appearance of RFP-labeled muscles. Results showed that only sr and mr/ir muscles exhibited in the myf5-MO-injected embryos and in the myf5-MO-six1a-mRNA-injected embryos (E vs. G and F vs. H). In contrast, only so, io, lap/do, ah, ao, and sh muscles exhibited in the myod-MO-injected embryos and in the myod-MO-six1a-mRNA-injected embryos (I vs. K and J vs. L). Similar to six1a morphants, embryos co-injected with six1a-MO and myf5 mRNA exhibited the so, io, sr, lr and remnant dorsal branchial arch muscles. However, injection of myf5 mRNA enabled embryos to rescue only sh primordia muscle among defects induced by six1a-MO (M, N), while injection of myod mRNA enabled embryos to rescue all the defective muscle primordia induced by six1a-MO (O, P). The rescued muscles are marked in green typeface. Lateral view: A, C, E, G, I, K, M and O; Ventral view: B, D, F, H, J, L, N and P. ah, adductor hyoideus; am, adductor mandibulae; ao, adductor operculi; do, dilator operculi; hh, hyohyoideus; ih, interhyoideus; ima, intermandibularis anterior; imp, intermandibularis posterior; io, inferior oblique; ir, inferior rectus; lap, levator arcus palatini; lr, lateral rectus; mr, medial rectus; sh, sternohyoideus; so, superior oblique and sr, superior rectus. The morphological defects were observed at 72 hpf. Absent-muscle defect indicated that mr, ir and ventral arch muscles were completely lost but the remnants of dorsal arch muscles still remained. Reduced-muscle defect indicated that mr, ir and all arch muscles were partially lost. Wild-type like phenotype indicated that the head muscles were not lost. t2:11 a The sh muscle was not included because it originates from the trunk. (Fig. 6E) . We also detected six1a, 439 myf5 and myod expressions in the tbx1-MO-injected embryos.
440
Results showed that the expressions of six1a, myf5 and myod were six1a-, myf5-or myod mRNA was co-injected with tbx1-MO, we 445 found that myf5-mRNA (Fig. 6G ), but not six1a-mRNA or myod 446 mRNA, enabled rescue of embryos from the defects induced by tbx1-447 MO (Figs. 6F, H) . This evidence strongly suggests that tbx1 is an 448 upstream modulator of myf5, regulating the specification of cranial 449 muscle development through myf5; however, the findings also 450 indicate that tbx1 is not a direct upstream regulator of six1a. (D-F) ; however, co-injection of six1a mRNA enabled embryos to rescue the defective expressions of RFP, myf5 and myod in sh, fb and phm primordia induced by six1a-MO at 48 hpf (H, I) and at 72 hpf (G). Meanwhile, injection of myf5 mRNA enabled embryos to rescue the defective expressions of RFP, myod and myogenin in sh, fb and phm primordia induced by six1a-MO at 48 hpf (K, L) and at 72 hpf (J). Injection of myod mRNA enabled embryos to rescue the defective expressions of RFP, myf5 and myogenin in sh, fb and phm primordia induced by six1a-MO at 48 hpf (N, O) and at 72 hpf (M). fb, fin bud; phm, posterior hypoaxial muscle; and sh, sternohyoideus.
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embryos. In addition, we injected eya1-MO into the embryos 6 . The function of Six1a in branchial muscle development requires Tbx1 and Myf5 to play a specification role on arch muscle cell fate. Embryos derived from the wild-type strain (A-D) and from the transgenic line Tg(α-actin:RFP) (E-H) were examined at lateral view. Whole-mount in situ hybridization was used to detect the tbx1 expression in arch muscle and cranial mesoderm in wild-type embryos at 36 hpf (A). Compared to the above control embryos, the expressions of six1a (B), myf5 (C) and myod (D) in the 10 ng group of tbx1-MO-injected embryos were lost in arch muscles, but retained in extraocular muscles. We also observed that all the pharyngeal arch muscles were lost, but that 6 extraocular muscles developed normally in the 10 ng group of tbx1-MO-injected embryos derived from Tg(α-actin:RFP) at 72 hpf (E). With co-injection of 10 ng of tbx1-MO and either 150 pg of six1a mRNA (F), 100 pg of myf5 mRNA (G) or 50 pg of myod mRNA (H) in embryos, we found that only myf5 mRNA enabled embryos to rescue the RFP expression in lap, do, ah, ao, am, ima/ imp and ih/hh (marked in green typeface of G). The heart defect induced by injection of tbx1-MO is labeled with a white star. ah, adductor hyoideus; am, adductor mandibulae; ao, adductor operculi; do, dilator operculi; hh, hyohyoideus; ih, interhyoideus; ima, intermandibularis anterior; imp, intermandibularis posterior; io, inferior oblique; ir, inferior rectus; lap, levator arcus palatini; lr, lateral rectus; mr, medial rectus; sh, sternohyoideus; so, superior oblique and sr, superior rectus. Embryos were all lateral views. Fig. 7 . Similar to Six1a, Pax3 is required for the development of mr, ir and all arch muscles. Embryos derived from the wild-type strain (A-F) and from the transgenic line Tg(α-actin: RFP) (G-R) were examined. Whole-mount in situ hybridization was used to detect the expressions of myf5 and myod at 48 hpf in the wild-type embryos, which served as a control group (A, D). Compared to the control group, embryos injected with 3 ng of pax3-MO exhibited a normal expression of myf5 in head muscle primordia at 48 hpf (B), but these embryos expressed myod only in so/sr, lr, io, and some remnant branchial muscles (E). Embryos injected with 10 ng of eya1-MO expressed myf5 and myod normally in head muscle primordia at 48 hpf (C, F). We also noticed that the RFP expression of embryos injected with six1a-MO was similar to that of control group at 72 hpf (G vs. J). The RFP signal appeared in the so, io, sr, lr and some remnant branchial muscles in pax3-MO-injected embryos, which was similar to that of the six1a morphants at 72 hpf (G vs. H and J vs. K). The RFP signal appeared in all cranial muscles of the eya1-MO-injected embryos at 72 hpf (I and L). By co-injection of 10 ng of pax3-MO with 150 pg of six1a mRNA (M, P), 100 pg of myf5 mRNA (N, Q) or 50 pg of myod mRNA (O, R), we found that the defective expressions of six1a, myf5 and myod could not be rescued in the pax3 morphants. (Fig. 8) . of the embryos from the defects induced by tbx1-MO (Fig. 6) . We 521 therefore propose that tbx1 determines cell fates to myogenic lineage 522 through the modulation of myf5. Once myf5 is expressed, myod 523 expression starts to increase. On the other hand, we found that myf5 524 was expressed normally in the embryos injected with either six1a-or 525 pax3-MO (Figs. 2, 7) , whereas myod (Figs. 2, 7) and myogenin (Fig. 2) 526 transcripts were severely reduced in the dorsal arch of six1a-and 527 pax3-morphants. In addition, injection of myod mRNA enables rescue 528 of embryos from the defects induced only by six1a-MO (Figs. 3, 7) .
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529
Taken together, we conclude that six1a and pax3 are not involved in Fig. 8 . Regulatory network model for tbx1, six1a, pax3, myf5 and myod, which are involved in the craniofacial muscle development of zebrafish embryos. Based on the evidence presented in this study, we propose that the development of all cranial muscles of zebrafish is through four regulatory pathways, which is a modification of model presented by Lin et al. (2006) . To summarize, Pathway I (marked in green): for dorsal arch muscles, lap, do, ah, ao and am. The myogenic regulatory factor tbx1 activates myf5 to initiate myogenesis. As a consequence, the basal level of myf5 triggers myod expression to further myogenic processes. Subsequently, myod, which is directly controlled by six1, but indirectly controlled by pax3, maintains and enhances a high level of myogenesis. Pathway II (marked in yellow): for the precursors of ventral arch muscles, ima, imp, ih and hh. Before subdivision, tbx1 activates myf5 expression to determine the myogenic cell fate. After subdivision, the major role of myod is to trigger the continuation of myogenic processes. Subsequently, myod, which is directly controlled by six1a, but indirectly controlled by pax3, maintains and enhances a high level of myogenesis. Pathway III (marked in red): for extraocular muscles, mr and ir. The myogenic regulatory factor myod initiates myogenesis, and its expression is controlled by six1a directly, and by pax3 indirectly, to maintain and enhance myogenesis. Pathway IV (marked in blue): for trunk migratory head muscle, sh. The MRF six1a directly controls both myf5 and myod in the myogenesis process, but myf5 and myod have redundant function.
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level of myod transcripts so that myogenesis can be processed. We also 532 notice that myod mRNA enables rescue of embryos from the defects 533 induced by six1a-MO, but not by pax3-MO, suggesting that, while the 534 expression of myod in the dorsal arch is directly controlled by six1a, it 535 is only indirectly controlled by pax3, perhaps through the interaction 536 of still unknown regulatory modules.
537
Pathway II is involved in ventral arch muscle development.
538
Ventral mesodermal core primordia originate from the myf5-positive 539 core and require Tbx1 and Myf5 to initiate myogenic lineage. In this 540 study, we found that the expressions of six1a and myod are lost in 541 the ventral arch region of tbx1 morphants, but that this defect can be 542 rescued by overexpression of myf5 mRNA (Fig. 6) . Therefore, we 543 propose the involvement of two steps in the development of ventral 544 arch muscle: tbx1 initiates myf5 expression in the beginning, and, 545 subsequently, six1a enhances and maintains myod expression.
546
Furthermore, similar to Pathway I in dorsal arch, we also found 547 that the expressions of myod (Figs. 2, 7) and myogenin (Fig. 2) 
556
Pathway Ш is involved in the development of extraocular muscles, 557 mr and ir. We found that six1a and myod transcripts are detected, but 558 not myf5 transcript, in mr and ir (Fig. 1) . Meanwhile, the expressions 559 of myod (Figs. 2, 7> ) and myogenin (Fig. 2) were lost in the mr and ir 560 of six1a-and pax3-morphants. Injection of myod mRNA enables 561 rescue of embryos from the defects induced by six1a-MO, but not 562 induced by pax3-MO (Figs. 3, 7) . Therefore, myod is required for the 563 development of mr and ir, and myod is directly regulated by six1a.
564
Interestingly, although six1a and myod transcripts are expressed in all 565 extraocular muscles, the so, io, sr and lr are still observed in the six1a 566 morphants, suggesting that other factors may be involved in 567 controlling the development of so, io, sr and lr.
568
Pathway IV is involved in the development of sh primordia, which 569 originates from anterior trunk somites. We found that the transcript 570 of sh was lost in the six1a morphants, but injection of either myf5 571 mRNA or myod mRNA enables embryos to be rescued from this defect 572 (Fig. 5) . Since sh muscle is derived from anterior trunk somites, the 573 regulatory mechanisms controlling the muscle development between 574 head and trunk paraxial mesoderm are different. This evidence 575 suggests that six1a is governed by a head-specific regulatory cascade 576 in cranial myogenesis, which is fundamentally distinct from that expressions of myod and myogenin, while myf5 is expressed normally.
587
Because of the existence of myf5 in these muscles, the remaining arch 588 muscles in Six1a knockdown embryos are observed. Nevertheless, 589 myod transcripts are reduced, with the result that these muscles 590 eventually lose their function (Fig. 3) . Like branchiomeric muscles, the 591 extraocular muscles originate from cranial paraxial mesoderm. Both 592 six1a and myod transcripts are expressed in mr and sr muscles at 593 32 hpf, whereas myf5 is not expressed (Fig. 2) . Thus, when six1a is 594 knocked down, the myod transcripts are lost, with the result that 595 muscle primordia of mr and ir are not developed (Fig. 3) . On the other 596 hand, unlike branchiomeric muscles and extraocular muscles, the 597 cranial muscle sh originates from trunk paraxial mesoderm, which is 598 named dermomyotome. During sh muscle development, Six1a is 599 required for both myf5 and myod expressions (Fig. 5) enabled rescue of embryos from all defective cranial muscles (Fig. 4) .
606
Based on these findings, it seems clear that the modulatory network 607 between Six1a and these two MRFs in cranial paraxial mesoderm is 608 quite different from that which is observed in trunk (sh) paraxial 609 mesoderm. This conclusion is similar to, and supported by, the 
618
The six genes constitute a large family of genes that are highly suggests that the stratum and extent of gene regulation are different.
725
Therefore, we conclude that Six1a plays a more dominant function 726 than Eya1 during head muscle development of zebrafish.
727
Regarding Pax3, when we knocked down pax3, the defective 728 phenotypes of cranial muscles were found to be similar to those of 729 six1a morphants (Fig. 7) . However, co-injection of six1a-, myf5-or 730 myod mRNA failed to rescue the defects induced by pax3-MO (Fig. 7) .
731
By comparing the expression patterns among pax3, six1a, myf5 and 732 myod, it can be seen that pax3 is not expressed in head muscle 733 primordia (Supplemental Fig. S6 
